Classic psychedelics, health behavior, and physical health.

IF 3.4 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Therapeutic Advances in Psychopharmacology Pub Date : 2022-11-30 eCollection Date: 2022-01-01 DOI:10.1177/20451253221135363
Otto Simonsson, Peter S Hendricks, Richard Chambers, Walter Osika, Simon B Goldberg
{"title":"Classic psychedelics, health behavior, and physical health.","authors":"Otto Simonsson, Peter S Hendricks, Richard Chambers, Walter Osika, Simon B Goldberg","doi":"10.1177/20451253221135363","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Preliminary evidence suggests that classic psychedelics may be effective in the treatment of some psychiatric disorders, yet little remains known about their effects on health behavior and physical health.</p><p><strong>Objectives: </strong>The purpose of this study was to investigate associations of lifetime classic psychedelic use and psychological insight during one's most insightful classic psychedelic experience with health behavior and physical health.</p><p><strong>Methods: </strong>Using data representative of the US population with regard to sex, age, and ethnicity (<i>N</i> = 2822), this study examined associations of lifetime classic psychedelic use and psychological insight with health behavior and physical health.</p><p><strong>Results: </strong>Lifetime classic psychedelic use was associated with more healthy tobacco-related and diet-related behavior (<i>β</i> = 0.05 and 0.09, respectively). Among lifetime classic psychedelic users (<i>n</i> = 613), greater Psychological Insight Questionnaire (PIQ) total scale, PIQ Avoidance and Maladaptive Patterns (AMP) subscale, and PIQ Goals and Adaptive Patterns (GAP) subscale scores were each associated with higher odds of more healthy exercise-related behavior [adjusted odds ratios (aOR) (95% confidence interval, CI = 1.38 (1.13-1.68), 1.38 (1.13-1.68), and 1.32 (1.10-1.60), respectively] and higher odds of having a healthy body mass index (BMI) [aOR (95% CI) = 1.32 (1.07-1.63), 1.36 (1.10-1.69), and 1.23 (1.01-1.50), respectively], and greater GAP subscale scores were associated with more healthy diet-related behavior (<i>β</i> = 0.10). All PIQ scales were positively associated with some health behavior improvements (overall, diet, exercise) attributed to respondents' most insightful classic psychedelic experience (<i>β</i> = 0.42, 0.18, and 0.17; <i>β</i> = 0.40, 0.19, and 0.17; and <i>β</i> = 0.40, 0.15, and 0.15, respectively), but only PIQ total scale and AMP subscale scores were positively associated with alcohol-related health behavior improvements (<i>β</i> = 0.13 and 0.16, respectively).</p><p><strong>Conclusion: </strong>Although these results cannot demonstrate causality, they suggest that psychological insight during a classic psychedelic experience may lead to positive health behavior change and better physical health in some domains, in particular in those related to weight management.</p>","PeriodicalId":23127,"journal":{"name":"Therapeutic Advances in Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716448/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20451253221135363","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Preliminary evidence suggests that classic psychedelics may be effective in the treatment of some psychiatric disorders, yet little remains known about their effects on health behavior and physical health.

Objectives: The purpose of this study was to investigate associations of lifetime classic psychedelic use and psychological insight during one's most insightful classic psychedelic experience with health behavior and physical health.

Methods: Using data representative of the US population with regard to sex, age, and ethnicity (N = 2822), this study examined associations of lifetime classic psychedelic use and psychological insight with health behavior and physical health.

Results: Lifetime classic psychedelic use was associated with more healthy tobacco-related and diet-related behavior (β = 0.05 and 0.09, respectively). Among lifetime classic psychedelic users (n = 613), greater Psychological Insight Questionnaire (PIQ) total scale, PIQ Avoidance and Maladaptive Patterns (AMP) subscale, and PIQ Goals and Adaptive Patterns (GAP) subscale scores were each associated with higher odds of more healthy exercise-related behavior [adjusted odds ratios (aOR) (95% confidence interval, CI = 1.38 (1.13-1.68), 1.38 (1.13-1.68), and 1.32 (1.10-1.60), respectively] and higher odds of having a healthy body mass index (BMI) [aOR (95% CI) = 1.32 (1.07-1.63), 1.36 (1.10-1.69), and 1.23 (1.01-1.50), respectively], and greater GAP subscale scores were associated with more healthy diet-related behavior (β = 0.10). All PIQ scales were positively associated with some health behavior improvements (overall, diet, exercise) attributed to respondents' most insightful classic psychedelic experience (β = 0.42, 0.18, and 0.17; β = 0.40, 0.19, and 0.17; and β = 0.40, 0.15, and 0.15, respectively), but only PIQ total scale and AMP subscale scores were positively associated with alcohol-related health behavior improvements (β = 0.13 and 0.16, respectively).

Conclusion: Although these results cannot demonstrate causality, they suggest that psychological insight during a classic psychedelic experience may lead to positive health behavior change and better physical health in some domains, in particular in those related to weight management.

Abstract Image

Abstract Image

Abstract Image

经典迷幻药、健康行为和身体健康。
背景:初步证据表明,经典迷幻药对治疗某些精神疾病可能有效,但对其对健康行为和身体健康的影响却知之甚少:本研究的目的是调查终生使用经典迷幻药以及在最深刻的经典迷幻药体验中的心理洞察力与健康行为和身体健康之间的关系:本研究使用了在性别、年龄和种族方面具有代表性的美国人口数据(N = 2822),研究了终生使用经典迷幻药和心理洞察力与健康行为和身体健康的关系:结果:终生使用经典迷幻药与更健康的烟草相关行为和饮食相关行为有关(β = 0.05 和 0.09)。在终生经典迷幻药使用者(n = 613)中,心理洞察力问卷(PIQ)总分、心理洞察力问卷回避和不良适应模式(AMP)分量表以及心理洞察力问卷目标和适应模式(GAP)分量表得分越高,与更健康的运动相关行为相关的几率就越高[调整后的几率比(aOR)(95% 置信区间,CI = 1.分别为 1.38 (1.13-1.68)、1.38 (1.13-1.68) 和 1.32 (1.10-1.60)],以及更高的健康体重指数 (BMI) [aOR (95% CI) = 1.32 (1.07-1.63)、1.36 (1.10-1.69) 和 1.23 (1.01-1.50)],而更高的 GAP 子量表得分则与更健康的饮食相关行为有关 (β = 0.10)。所有 PIQ 量表均与受访者最深刻的经典迷幻体验所带来的某些健康行为改善(总体、饮食、运动)呈正相关(β = 0.42、0.18 和 0.17;β = 0.40、0.19 和 0.17;以及 β = 0.40、0.15 和 0.15),但只有 PIQ 总量表和 AMP 子量表得分与酒精相关健康行为改善呈正相关(β = 0.13 和 0.16):尽管这些结果不能证明因果关系,但它们表明,在经典迷幻体验中的心理洞察力可能会导致积极的健康行为改变,并在某些领域改善身体健康,尤其是与体重管理相关的领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.90
自引率
2.40%
发文量
35
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in psychopharmacology, providing a forum in print and online for publishing the highest quality articles in this area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信